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A case of multifocal Langerhans cell histiocytosis in a two-year-old child is presented where ﬁne needle aspiration was helpful in
achieving a rapid and accurate diagnosis in an appropriate clinical and radiological setting. This can avoid unnecessary biopsy and
guide the management especially where access to histopathology is limited. The highly characteristic common and rare cytological
features are highlighted with focus on diﬀerential diagnoses and causes of pitfalls.
1.Introduction
Langerhans cell histiocytosis (LCH) is a rare disease aﬀecting
predominantly children. It can present as a solitary lesion
requiring no treatment or as a multisystem, life-threatening
disorder necessitating aggressive therapy [1].
We present a case of LCH in a child where ﬁne needle
aspiration (FNA) was helpful in establishing a rapid and
correct diagnosis in correlation with radiology. The purpose
is to highlight common and rare cytological features. This
will add to the pathologist’s conﬁdence in rendering a
rapid and accurate cytologic diagnosis, avoid unnecessary
biopsy and guide appropriate management. This is especially
valuable in a setting where cytopathologist expertise may not
be easily available and histopathology services are located
onlyinbigcitiesandareinaccessibletopatientsinruralareas
due to the long distance and high cost involved.
2.CaseReport
A two-year-old female child presented to the outreach centre
of our university hospital with swellings on right frontal
and occipital regions of skull for the last one year. On
examination, these were ﬂuctuant, ill-deﬁned soft tissue
masses which measured 2×2a n d3×3cms,respectively .In
addition, a cervical lymph node was palpable on the left side
measuring 1×1cms. It was ﬁrm, tender, and slightly mobile.
The patient had no fever or loss of weight. The liver and
spleen were not palpable.
Peripheral blood ﬁlm showed microcytic hypochromic
anemia. Hemoglobin was 10gm/dL. Diﬀerential count
showed 19% monocytosis with 38.3% neutrophils, 38.9%
lymphocytes, 2.5% eosinophils, and 1.3% basophils. Platelet
count was normal. The initial clinical impression favored a
malignant lesion. The patient was referred for FNA.
FNA from lymph node yielded whitish aspirate. FNA
from right frontal and occipital masses yielded 0.5mL
and 1mL hemorrhagic ﬂuid, respectively. The ﬂuid was
centrifuged to make smears from the sediment. Ethanol-
ﬁxed smears and air-dried smears were prepared and stained
with Papanicolaou and Giemsa method, respectively. The
remaining sediment was processed to make cell block for
immunochemistry.
Smears were highly cellular and showed numerous
atypical histiocytes as the predominant cell type scattered
singly and in loosely cohesive clusters. These were admixed
with a polymorphic population of eosinophils, neutrophils,
lymphocytes, plasma cells, foamy histiocytes, and multin-
ucleated reactive histiocytic giant cells (Figure 1). Smears
from both the swellings in the skull and cervical lymph node2 Pathology Research International
were morphologically similar except that atypical histiocytes
were less in number and eosinophils were more abundant in
smears from lymph node as compared to smears from skull
lesions.
The atypical histiocytes were large cells with moderate
to abundant, pale blue cytoplasm and an eccentric or
central round to oval, vesicular nuclei. Prominent nuclear
indentations and grooves (with a coﬀee bean appearance)
were observed which were best seen in Papanicolaou stain
(Figure 2). Some showed intranuclear pseudoinclusions.
Nucleoli were absent. These cells displayed marked pleo-
morphism with variation in size and shape of cells and
nuclei. Occasional mitoses were seen. Some of these cells
showed cytoplasmic processes. Most were mononuclear, and
some were binucleate or multinucleated. The multinucleated
giantcellshadcomplexfoldednucleisimilartomononuclear
atypical histiocytes and were easily diﬀerentiated from
reactive multinucleated histiocytic giant cells.
The multinucleated reactive histiocytic giant cells con-
tained numerous indented vesicular nuclei in abundant
cytoplasm. They also contained hemosiderin in smears
from skull masses (Figure 1). In addition, many rhomboid
and needle-shaped Charcot-Leyden crystals were seen both
extracellular (Figure 3(a)) and intracellular in the giant cells
(Figure 3(b)). The atypical histiocytes stained positive for
both cytoplasmic and nuclear S-100 protein. The cytologic
ﬁndings were highly suggestive of LCH.
At this point, a plain X-ray was requested which showed
two lytic lesions corresponding to occipital and frontal
swellings. Subsequently, computerized tomogram (CT) with
3D reconstruction showed lytic lesions which were clearly
demarcated “punched-out” lesions (the classic geographic
skull) in frontal and occipital regions. There was associated
homogenous soft tissue swelling of the scalp but no breech
of the dura. No other systemic involvement was found.
3. Discussion
LCH is a rare disease, and the estimated annual incidence
ranges from 0.5 to 5.4 cases per million persons [2]. In
the past, the disorder was referred to as histiocytosis X and
had three variants: eosinophilic granuloma, Hand-Schuller-
Christian disease and Letterer-Siwe syndrome. These three
conditions are believed to represent diﬀerent expressions of
the same disorder, now known as LCH [3, 4].
An ongoing debate exists over whether this is a reactive
or neoplastic process [2]. The disease is characterized by a
clonal proliferation of the antigen-presenting dendritic cell
called the Langerhans cell (LC) [5, 6]. The proliferation
may be induced by a viral infection, a defect in T cell-
macrophage interaction, and/or a cytokine-driven process
mediated by tumor necrosis factor, interleukin 11, and
leukemia inhibitory factor [2, 7–10].
LCH may occur at any age, although the majority
of the cases are diagnosed in children from newborn to
15 years. There is no signiﬁcant gender diﬀerence. The
clinical spectrum varies from a solitary lesion, to multifocal
unisystem to multisystem lesions with related symptoms.
The unifocal form usually involves the bone, often seen in
Figure 1: FNA smear from frontal mass showing single and loosely
clustered Langerhans cells admixed with neutrophils, lymphocytes
and, reactive histiocytes. Two foamy macrophages containing
hemosiderin are seen in the centre (Papanicolaou stain, original
magniﬁcation, ×400).
Figure 2: Langerhans cells with moderate to abundant cytoplasm
and prominent nuclear grooves (Papanicolaou stain, original
magniﬁcation, ×400).
children between 5 and 15 years old. Systemic LCH is more
common in children under 2 years of age. The multifocal
unisystem form almost always occurs in the bone. Any bone
can be involved, but more than 50% of lesions occur in
the skull, spine, pelvis, ribs, and mandible. The multifocal
multisystem form involves many organs, including the bone,
skin, liver, spleen, hematopoietic system, and lymph node
[2, 11]. The lymph node involvement in LCH can be seen as
a part of a systemic disease or as a localized lesion, although
isolated nodal involvement is rare. Lymph node may also
enlarge as a reaction to bone or skin lesions [12].
Traditionally, the diagnosis of LCH is based on hema-
tologic and histologic criteria [2, 4, 13–15]. Enough expe-
rience has accumulated in accurate cytological diagnosis of
LCH in various body sites on the basis of characteristic
cytological features in the presence of appropriate clinical
and radiological setting as evident from several case reportsPathology Research International 3
(a) (b)
Figure 3: (a) Extracellular rhomboid Charcot-Leyden crystals (Papanicolaou stain, original magniﬁcation, x400). (b) Macrophages with
several ingested Charcot-Leyden crystals (Papanicolaou stain, original magniﬁcation, x400).
and case series [16–31]. Study of these shows that cytology
closely reﬂects histomorphology. Ancillary studies may not
be always necessary for diagnosis in appropriate setting [32].
The classical cytological features include high cellularity
composed of sheets and many isolated LCs seen admixed
with polymorphous population of numerous eosinophils,
neutrophils, lymphocytes, plasma cells, multinucleated giant
cells,andmacrophages.Thekeytothediagnosisistoidentify
the LC through its characteristic features, namely, nuclear
grooves and nuclear pseudoinclusions. They show variable
degree of pleomorphism and mitotic activity [17, 18, 22, 26,
29]. Presence of dendrite-like cytoplasmic processes in LCs
is a rare but characteristic feature [22, 33, 34]. Sometimes
the LCs are few or nuclear grooves not very prominent or
lack cytopalsmic processes. Degree of eosinophil inﬁltration
varies in diﬀerent areas of LCH lesion and diﬀerent organs,
thus their number can vary from scant to abundant in cytol-
ogy smears [22]. Their presence can help attract attention to
the diagnosis. In our case, eosinophils were more abundant
inlymphnodesmearsascomparedtoskulllesionswhichhad
more of LCs and reactive histiocytes.
Presence of Charcot-Leyden crystals singly and in
bunches within the macropahges, giant cells, and extar-
cellularly was a unique feature in our case and has been
reported very rarely [20, 27, 29, 31]. Charcot-Leyden crystals
are crystalloids containing eosinophil membrane protein
formed from rupture of eosinophil’s granules. They indicate
tissue eosinophilia and may help in drawing attention to the
LCH diagnosis.
The diagnosis of LCH in our patient was made on the
basis of FNA which showed characteristic (both common
and rare) features of LCH. This was corroborated by
characteristic radiology and clinical ﬁndings. In this case, CT
showed lytic lesions in the skull bones having sharp borders
with a punched-out appearance. Destruction of both the
innerandoutertablesresultsinadouble-contourorbeveled-
edge appearance which is a typical feature in the diagnosis of
LCH [35, 36].
The cytologic diagnosis may be missed due to lack of
familiarity with its cytological features among pathologists
or due to the lack of characteristic cytological ﬁndings
resulting from a sampling error. Therefore it is prudent on
the part of the pathologist to consider this diagnosis only
in an appropriate clinical and radiological setting. It is also
necessary to be familiar with cytological features of other
diﬀerential diagnoses.
In the present case, the most common diﬀerential
diagnoses of skull lesions clinically included Ewing’s sar-
coma, non-Hodgkin lymphoma, and osteomyelitis. Ewing’s
sarcoma and non-Hodgkin lymphoma are characterized by
monotonous population of small round blue cells. In acute
osteomyelitis, theneutrophils formaprominent component.
The reactive histiocytes are seen and can be easily distin-
guished due to the absence of distinctive features of LCs.
Chronic osteomyeltis shows predominantly plasma cells and
lymphocytes. Plasma cells and neutrophils are infrequent in
LCH.
Sinus histiocytosis with massive lymphadenopathy
(SHML) involves primarily the cervical nodes, but its
histiocytes are morphologically quite diﬀerent from those of
LCH. In SHML, the histiocytes have abundant cytoplasm,
exhibiting hematopoietic phagocytosis and prominent
nucleoli [28].
Secondary hyperplasia of the LCs is associated with
lymphomas, especially with Hodgkin’s disease and lung
tumors. Care should be taken to diﬀerentiate these hyper-
plastic Langerhans cells from atypical LCs of LCH. Rarely,
LCH can be associated with another malignancy such as
malignantlymphoma,leukemia,ormetastaticneoplasm[37,
38]. These need to be excluded after a diligent search for
malignant cells with obvious cytologic atypia in the smear.
Malignancies with tumor cells commonly having nuclear
grooves or pseudoinclusions should also be considered, such
as malignant melanoma and papillary thyroid carcinoma.
LCs show positivity for S-100, PNA (peanut agglutinin),
MHC class II, CD1a, and langerin (CD207) [2]. Our case4 Pathology Research International
showed positivity for S-100 protein. CD1a and langerin
are not available in our lab. The Birbeck granule is their
distinctive ultrastructural hallmark [2]. Electron microscopy
was not performed in our patient and was not considered
essential for diagnosis as also suggested by other authors
[32].
Patients with apparently restricted LCH need careful
staging of their disease to ensure that the lesions are not part
of a more extensive process. FNA can be used to establish
the extent of disease or recurrence of LCH [18]. In children
with multiple swellings as in our case, FNA, being minimally
invasive, is particularly suitable to sample all swellings in
detecting the extent of involvement. For localized lesions
in the skeletally immature patients, a simple, minimally
invasive form of treatment with a low rate of complication is
desirable. In view of this and the possibility of spontaneous
resolution in localized disease, FNA alone could be used to
conﬁrm the diagnosis.
To conclude, the present case highlights the role of FNA
in the diagnosis of the rare disease of LCH in a child with
usual clinical presentation. The cytologic features of LCH
are highly characteristic to suggest a diagnosis in an appro-
priate clinical setting with classical radiological ﬁndings. A
high index of suspicion, awareness of common and rare
cytological features of LCH, its diﬀerential diagnoses, and
causes of diagnostic pitfalls is necessary. This can obviate the
need of biopsy and electron microscopy. Immunochemistry
if available can be performed on cell block.
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